A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells

This publication has 22 references indexed in Scilit:

• Structure and in vivo function of Hsp90
  Current Opinion in Structural Biology, 2000
• Geldanamycin as a Potential Anti-Cancer Agent: Its Molecular Target and Biochemical Activity
  Investigational New Drugs, 1999
• Hsp90 & Co. – a holding for folding
  Trends in Biochemical Sciences, 1999
• The Hsp90 complex—a super-chaperone machine as a novel drug target
  Biochemical Pharmacology, 1998
• Recent Advances in the Study of hsp90 Structure and Mechanism of Action
  Trends in Endocrinology & Metabolism, 1998
• The hsp90-based Chaperone System: Involvement in Signal Transduction from a Variety of Hormone and Growth Factor Receptors
  Experimental Biology and Medicine, 1998
• The Physical Association of Multiple Molecular Chaperone Proteins with Mutant p53 Is Altered by Geldanamycin, an hsp90-Binding Agent
  Molecular and Cellular Biology, 1998
• THE ROLE OF THEhsp90-BASED CHAPERONE SYSTEM IN SIGNAL TRANSDUCTION BY NUCLEAR RECEPTORS AND RECEPTORS SIGNALING VIA MAP KINASE
  Annual Review of Pharmacology and Toxicology, 1997
• Association of Hsp90 with Cellular Src-Family Kinases in a Cell-Free System Correlates with Altered Kinase Structure and Function
  Biochemistry, 1994
• Unusual expression and localization of heat‐shock proteins in human tumor cells
  International Journal of Cancer, 1992